Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel.

Name: Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel.
Author: Russo, Alessandro

Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel. — المؤلف: Russo, Alessandro — Journal of cellular physiology 20190930

المؤلف: Russo, Alessandro
النشر: Journal of cellular physiology 20190930
الوصف: 6337-6343 p.
الموضوعات: Adult؛ Aged؛ Biomarkers, Tumor؛ Blood Platelets؛ Carcinoma, Non-Small-Cell Lung؛ Docetaxel؛ Drug-Related Side Effects and Adverse Reactions؛ Female